Moxifloxacin Sandoz

Moxifloxacin, the active ingredient in Moxifloxacin Sandoz, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections in adults, including pneumonia, sinusitis, bronchitis, skin infections and intra‑abdominal infections.

GNH USA supplies Moxifloxacin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Moxifloxacin Sandoz is a fluoroquinolone that targets bacterial DNA replication in several infection types.

Community‑acquired bacterial pneumonia: effective treatment of infection caused by susceptible organisms. Acute bacterial sinusitis: eradicates the causative pathogens and relieves sinus inflammation. Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory symptoms. Skin and skin structure infections: combats Gram‑positive and Gram‑negative bacteria in soft‑tissue infections. Intra‑abdominal infections: provides coverage against mixed aerobic and anaerobic organisms.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting - Diarrhea or loose stools - Headache - Dizziness or vertigo - Rash or mild skin irritation - Photosensitivity to sunlight

Serious or Rare Side Effects: - Tendon rupture or tendonitis, especially in the Achilles tendon - QT interval prolongation leading to cardiac arrhythmias - Clostridioides difficile‑associated colitis - Severe allergic reactions such as anaphylaxis - Peripheral neuropathy - Hepatic dysfunction or elevated liver enzymes

Before prescribing Moxifloxacin Sandoz, clinicians should consider several safety factors.

Renal or hepatic impairment: monitor function and adjust therapy if needed. History of tendon disorders: avoid use due to risk of tendon rupture. QT prolongation risk: obtain baseline ECG and avoid in patients with known prolongation. Pregnancy and lactation: use only if benefits outweigh potential risks. Drug interactions: review concomitant medications for possible interactions. Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Moxifloxacin Sandoz can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of the drug. - Systemic corticosteroids: increase risk of tendon rupture. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Strong CYP450 inducers (e.g., rifampin): lower plasma concentrations of moxifloxacin.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system side effects. - Theophylline: may raise theophylline plasma levels, leading to toxicity. - Sulfonylureas or other antidiabetic agents: may alter glucose control, requiring monitoring.